NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Xenetic Biosciences Inc (NASDAQ: XBIOW)
XBIOW Technical Analysis
5
As on 9th Jun 2023 XBIOW SHARE Price closed @ 5.40 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.37 & Strong Buy for SHORT-TERM with Stoploss of 1.54 we also expect STOCK to react on Following IMPORTANT LEVELS. |
XBIOWSHARE Price
Open | 4.60 | Change | Price | % |
High | 5.40 | 1 Day | 0.90 | 20.00 |
Low | 4.60 | 1 Week | -17.76 | -76.68 |
Close | 5.40 | 1 Month | 3.40 | 170.00 |
Volume | 2000 | 1 Year | 4.40 | 440.00 |
52 Week High 23.16 | 52 Week Low 0.00 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
XBIOW Daily Charts |
XBIOW Intraday Charts |
Whats New @ Bazaartrend |
XBIOW Free Analysis |
|
XBIOW Important Levels Intraday
RESISTANCE | 6.94 |
RESISTANCE | 6.45 |
RESISTANCE | 6.14 |
RESISTANCE | 5.84 |
SUPPORT | 4.96 |
SUPPORT | 4.66 |
SUPPORT | 4.35 |
SUPPORT | 3.86 |
XBIOW Forecast April 2024
4th UP Forecast | 7.33 |
3rd UP Forecast | 6.71 |
2nd UP Forecast | 6.33 |
1st UP Forecast | 5.95 |
1st DOWN Forecast | 4.86 |
2nd DOWN Forecast | 4.47 |
3rd DOWN Forecast | 4.09 |
4th DOWN Forecast | 3.47 |
XBIOW Weekly Forecast
4th UP Forecast | 8.87 |
3rd UP Forecast | 7.76 |
2nd UP Forecast | 7.07 |
1st UP Forecast | 6.38 |
1st DOWN Forecast | 4.42 |
2nd DOWN Forecast | 3.73 |
3rd DOWN Forecast | 3.04 |
4th DOWN Forecast | 1.93 |
XBIOW Forecast2024
4th UP Forecast | 50.03 |
3rd UP Forecast | 35.72 |
2nd UP Forecast | 26.87 |
1st UP Forecast | 18.02 |
1st DOWN Forecast | -7.22 |
2nd DOWN Forecast | -16.07 |
3rd DOWN Forecast | -24.92 |
4th DOWN Forecast | -39.23 |
Xenetic Biosciences Inc ( NASDAQ USA Symbol : XBIOW )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
XBIOW Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
XBIOW Address
XBIOW Latest News
XBIOW Business Profile
Xenetic Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progestin resistant endometrial cancer. It is also developing ErepoXen, a drug using PolyXen platform technology for the treatment of anemia in chronic kidney disease patients. The company has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service